Symkinet MR
Description
Symkinet MR 10 mg, modified release capsules, hard
Symkinet MR 20 mg, modified release capsules, hard
Symkinet MR 30 mg, modified release capsules, hard
Symkinet MR 40 mg, modified release capsules, hard
Available in packs of 30 modified-release capsules, hard.
Active ingredient: Methylphenidati hydrochloridum
Indications: Symkinet MR is used to treat ‘Attention Deficit Hyperactivity Disorder’ (ADHD).
- It is used in children and adolescents between the ages of 6 and 18, and in adults.
- It is used only after treatments which do not involve medicine, such as counselling and behavioural therapy, and which have been insufficient.
Additional information
Molecules |
---|